Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Linlin Bao and Chuan Qin.
Linlin Bao
Connection Strength
5.090
Chuan Qin
  1. Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza. Signal Transduct Target Ther. 2021 05 20; 6(1):200.
    View in: PubMed
    Score: 0.946
  2. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature. 2020 07; 583(7818):830-833.
    View in: PubMed
    Score: 0.881
  3. SARS-CoV-2 infection aggravates chronic comorbidities of cardiovascular diseases and diabetes in mice. Animal Model Exp Med. 2021 03; 4(1):2-15.
    View in: PubMed
    Score: 0.233
  4. Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy. Cell. 2020 11 12; 183(4):1013-1023.e13.
    View in: PubMed
    Score: 0.226
  5. Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques. Nat Commun. 2020 09 02; 11(1):4400.
    View in: PubMed
    Score: 0.225
  6. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science. 2020 08 14; 369(6505):818-823.
    View in: PubMed
    Score: 0.223
  7. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. 2020 07 03; 369(6499):77-81.
    View in: PubMed
    Score: 0.220
  8. Age-related rhesus macaque models of COVID-19. Animal Model Exp Med. 2020 Mar; 3(1):93-97.
    View in: PubMed
    Score: 0.219
  9. From SARS to MERS, Thrusting Coronaviruses into the Spotlight. Viruses. 2019 01 14; 11(1).
    View in: PubMed
    Score: 0.201
  10. Neurotropism In Vitro and Mouse Models of Severe and Mild Infection with Clinical Strains of Enterovirus 71. Viruses. 2017 11 20; 9(11).
    View in: PubMed
    Score: 0.186
  11. Comparative Analysis of Serum Proteins from Patients with Severe and Mild EV-A71-induced HFMD using iTRAQ-Coupled LC-MS/MS Screening. Proteomics Clin Appl. 2017 Dec; 11(11-12).
    View in: PubMed
    Score: 0.185
  12. Comparative pathology of rhesus macaque and common marmoset animal models with Middle East respiratory syndrome coronavirus. PLoS One. 2017; 12(2):e0172093.
    View in: PubMed
    Score: 0.176
  13. [Clinical and Biological Character in Mouse Models for Middle East Respiratory Syndrome Generated by Transduction with Different Doses of DPP4 Molecule]. Bing Du Xue Bao. 2015 Nov; 31(6):593-600.
    View in: PubMed
    Score: 0.161
  14. Intranasal immunization of mice with inactivated virus and mast cell activator C48/80 elicits protective immunity against influenza H1 but not H5. Immunol Invest. 2014; 43(3):224-35.
    View in: PubMed
    Score: 0.141
  15. An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus. J Infect Dis. 2014 Jan 15; 209(2):236-42.
    View in: PubMed
    Score: 0.140
  16. Highly pathogenic avian influenza H5N1 virus could partly be evacuated by pregnant BALB/c mouse during abortion or preterm delivery. Virol J. 2011 Jul 08; 8:342.
    View in: PubMed
    Score: 0.119
  17. [Preventive and therapeutic effects of recombinant IFN-alpha2b nasal spray on SARS-CoV infection in Macaca mulata]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2005 Sep; 19(3):207-10.
    View in: PubMed
    Score: 0.080
  18. ACE2 expression is regulated by AhR in SARS-CoV-2-infected macaques. Cell Mol Immunol. 2021 05; 18(5):1308-1310.
    View in: PubMed
    Score: 0.059
  19. Publisher Correction: A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature. 2021 Feb; 590(7844):E23.
    View in: PubMed
    Score: 0.058
  20. Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19. Cell Host Microbe. 2021 02 10; 29(2):222-235.e4.
    View in: PubMed
    Score: 0.058
  21. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature. 2020 10; 586(7830):572-577.
    View in: PubMed
    Score: 0.056
  22. Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. Cell. 2020 08 06; 182(3):713-721.e9.
    View in: PubMed
    Score: 0.055
  23. Immunogenicity of a DNA vaccine candidate for COVID-19. Nat Commun. 2020 05 20; 11(1):2601.
    View in: PubMed
    Score: 0.055
  24. Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells. Cell. 2020 07 09; 182(1):73-84.e16.
    View in: PubMed
    Score: 0.055
  25. Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus. Emerg Microbes Infect. 2018 Apr 04; 7(1):60.
    View in: PubMed
    Score: 0.048
  26. Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset. J Infect Dis. 2017 06 15; 215(12):1807-1815.
    View in: PubMed
    Score: 0.045
  27. Treatment With Lopinavir/Ritonavir or Interferon-ß1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset. J Infect Dis. 2015 Dec 15; 212(12):1904-13.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.